ASX Share rice
Fri 14 May 2021 - 08:23:pm (Sydney)

MEM Share Price

MEMPHASYS LIMITED.MEMPharmaceuticals, Biotechnology & Life Sciences

MEM Company Information

Name:

Memphasys Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

30 Richmond Road Homebush NSW Australia 2140

Phone:

61 2 8415 7300

Exec. Chairman & Interim CEO:

Ms. Alison Mary Coutts B.E., M.B.A., B.E. (Chem), GDipBiotech, MBA

Director of Fin.:

Pablo Neyertz

Operations Mang.:

Nick Gorring

Chief Financial Officer of Nusep Ltd:

Mr. Malcolm Coleman

Company Sec.:

Mr. Andrew Metcalfe

Company Overview:

Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility; hydrogels; and other polymer membranes to separate cells from fluids. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is headquartered in Homebush, Australia.

MEM Share Price Information

Shares Issued:

759.77M

Market Capitalisation:

$42.55M

Earnings per Share:

$-0.003

Return On Assets (TTM):

$-0.07

Return On Equity (TTM):

$-0.12

Diluted Earnings Per Share (TTM):

$-0.001

MEM CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-3,110,312

Change To Liabilities:

$1.23M

Total Cashflow From Investing Activities:

$-3,110,312

Net Borrowings:

$-92,275

Net Income:

$-1,133,879

Total Cash From Operating Activities:

$92.81K

Depreciation:

$196.23K

Other Cashflow From Investing Activities:

$27.39K

Change To Inventory:

$-32,677

Change To Account Receivables:

$-277,275

Sale Purchase Of Stock:

$4.54M

Capital Expenditures:

$236.28K

MEM Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-1,133,880

Net Income:

$-1,133,880

Operating Income:

$-1,133,880

Interest Expense:

$38.76K

MEM Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$6.55M

Total Liabilities:

$1.54M

Total Stockholder Equity:

$9.76M

Other Current Liabilities:

$65.40K

Total Assets:

$11.30M

Common Stock:

$48.70M

Other Current Assets:

$48.04K

Retained Earnings:

$-39,680,991

Other Liabilities:

$25.04K

Cash:

$1.97M

Total Current Liabilities:

$586.78K

Property - Plant & Equipment:

$1.19M

Net Tangible Assets:

$3.21M

Total Current Assets:

$3.56M

Net Receivables:

$1.34M

Short-Term Investments:

$7.74M

Inventory:

$32.68K

Accounts Payable:

$218.65K

Short-Term Investments:

$7.74

Non Current Liabilities Total:

$0.96M

MEM Share Price History

MEM News

08 Sep, 2020
Just because a business does not make any money, does not mean that the stock will go down. Indeed, Memphasys...